Literature DB >> 17651432

Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization.

Amaury Fernández-Montalván1, Tewis Bouwmeester, Gerard Joberty, Robert Mader, Marion Mahnke, Benoit Pierrat, Jean-Marc Schlaeppi, Susanne Worpenberg, Bernd Gerhartz.   

Abstract

Ubiquitin specific protease 7 (USP7) belongs to the family of deubiquitinating enzymes. Among other functions, USP7 is involved in the regulation of stress response pathways, epigenetic silencing and the progress of infections by DNA viruses. USP7 is a 130-kDa protein with a cysteine peptidase core, N- and C-terminal domains required for protein-protein interactions. In the present study, recombinant USP7 full length, along with several variants corresponding to domain deletions, were expressed in different hosts in order to analyze post-translational modifications, oligomerization state, enzymatic properties and subcellular localization patterns of the enzyme. USP7 is phosphorylated at S18 and S963, and ubiquitinated at K869 in mammalian cells. In in vitro activity assays, N- and C-terminal truncations affected the catalytic efficiency of the enzyme different. Both the protease core alone and in combination with the N-terminal domain are over 100-fold less active than the full length enzyme, whereas a construct including the C-terminal region displays a rather small decrease in catalytic efficiency. Limited proteolysis experiments revealed that USP7 variants containing the C-terminal domain interact more tightly with ubiquitin. Besides playing an important role in substrate recognition and processing, this region might be involved in enzyme dimerization. USP7 constructs lacking the N-terminal domain failed to localize in the cell nucleus, but no nuclear localization signal could be mapped within the enzyme's first 70 amino acids. Instead, the tumor necrosis factor receptor associated factor-like region (amino acids 70-205) was sufficient to achieve the nuclear localization of the enzyme, suggesting that interaction partners might be required for USP7 nuclear import.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651432     DOI: 10.1111/j.1742-4658.2007.05952.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  45 in total

Review 1.  USP7: Structure, substrate specificity, and inhibition.

Authors:  Alexandra Pozhidaeva; Irina Bezsonova
Journal:  DNA Repair (Amst)       Date:  2019-02-16

Review 2.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

3.  Deubiquitylase, deSUMOylase, and deISGylase activity microarrays for assay of substrate preference and functional modifiers.

Authors:  Christian M Loch; Charles L Cuccherini; Craig A Leach; James E Strickler
Journal:  Mol Cell Proteomics       Date:  2010-10-18       Impact factor: 5.911

Review 4.  The role of deubiquitinating enzymes in chromatin regulation.

Authors:  Boyko S Atanassov; Evangelia Koutelou; Sharon Y Dent
Journal:  FEBS Lett       Date:  2010-10-26       Impact factor: 4.124

5.  Autocatalytic activity of the ubiquitin-specific protease domain of herpes simplex virus 1 VP1-2.

Authors:  M Bolstad; F Abaitua; C M Crump; P O'Hare
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

6.  USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy.

Authors:  Jessica A Hall; Mitsuhisa Tabata; Joseph T Rodgers; Pere Puigserver
Journal:  Mol Endocrinol       Date:  2014-04-02

7.  Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.

Authors:  Nuria Martínez-López; Marta Varela-Rey; David Fernández-Ramos; Ashwin Woodhoo; Mercedes Vázquez-Chantada; Nieves Embade; Luis Espinosa-Hevia; Francisco Javier Bustamante; Luis A Parada; Manuel S Rodriguez; Shelly C Lu; José M Mato; Maria L Martínez-Chantar
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

8.  Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.

Authors:  Anna Pluciennik; Yuhong Liu; Elana Molotsky; Gregory B Marsh; Bedri Ranxhi; Frederick J Arnold; Sophie St-Cyr; Beverly Davidson; Naemeh Pourshafie; Andrew P Lieberman; Wei Gu; Sokol V Todi; Diane E Merry
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

9.  Supervillin-mediated suppression of p53 protein enhances cell survival.

Authors:  Zhiyou Fang; Elizabeth J Luna
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

10.  The C. elegans Ortholog of USP7 controls DAF-16 stability in Insulin/IGF-1-like signaling.

Authors:  Thomas Heimbucher; Tony Hunter
Journal:  Worm       Date:  2015-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.